These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26012475)

  • 41. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
    Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-colon cancer effect of caffeic acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites.
    Tang H; Yao X; Yao C; Zhao X; Zuo H; Li Z
    Sci Rep; 2017 Aug; 7(1):7599. PubMed ID: 28790461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
    Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
    FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
    Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
    Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A.
    Liu Q; Basu S; Qiu Y; Tang F; Dong F
    Oncogene; 2010 May; 29(19):2843-52. PubMed ID: 20190815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
    He M; Wang QY; Yin QQ; Tang J; Lu Y; Zhou CX; Duan CW; Hong DL; Tanaka T; Chen GQ; Zhao Q
    Cell Death Differ; 2013 Mar; 20(3):408-18. PubMed ID: 23059786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
    PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
    Correia AC; Moonen JR; Brinker MG; Krenning G
    J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials.
    Tili E; Michaille JJ; Liu CG; Alder H; Taccioli C; Volinia S; Calin GA; Croce CM
    Nucleic Acids Res; 2010 Nov; 38(21):7673-88. PubMed ID: 20639536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.
    Hwang-Verslues WW; Sladek FM
    Mol Endocrinol; 2008 Jan; 22(1):78-90. PubMed ID: 17885207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
    Meerson A; Yehuda H
    BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells.
    Yoo YD; Choi JY; Lee SJ; Kim JS; Min BR; Lee YI; Kang YK
    Int J Cancer; 1999 Nov; 83(4):512-7. PubMed ID: 10508488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms.
    Shi X; Mihaylova VT; Kuruvilla L; Chen F; Viviano S; Baldassarre M; Sperandio D; Martinez R; Yue P; Bates JG; Breckenridge DG; Schlessinger J; Turk BE; Calderwood DA
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):E4558-66. PubMed ID: 27432991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
    Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
    Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
    Si W; Shen J; Du C; Chen D; Gu X; Li C; Yao M; Pan J; Cheng J; Jiang D; Xu L; Bao C; Fu P; Fan W
    Cell Death Differ; 2018 Feb; 25(2):406-420. PubMed ID: 29125598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.